Works by King, Madeleine

Results: 162
    1
    2
    3

    Preliminary evidence on the uptake, use and benefits of the CONSORT-PRO extension.

    Published in:
    2017
    By:
    • Mercieca-Bebber, Rebecca;
    • Rouette, Julie;
    • Calvert, Melanie;
    • King, Madeleine;
    • McLeod, Lori;
    • Holch, Patricia;
    • Palmer, Michael;
    • Brundage, Michael;
    • King, Madeleine T;
    • Palmer, Michael J;
    • International Society for Quality of Life Research (ISOQOL) Best Practice for PROs—Reporting Taskforce
    Publication type:
    journal article
    4
    5

    International Society for Quality of Life Research commentary on the draft European Medicines Agency reflection paper on the use of patient-reported outcome (PRO) measures in oncology studies.

    Published in:
    2016
    By:
    • Kyte, Derek;
    • Reeve, Bryce;
    • Efficace, Fabio;
    • Haywood, Kirstie;
    • Mercieca-Bebber, Rebecca;
    • King, Madeleine;
    • Norquist, Josephine;
    • Lenderking, William;
    • Snyder, Claire;
    • Ring, Lena;
    • Velikova, Galina;
    • Calvert, Melanie;
    • Reeve, Bryce B;
    • King, Madeleine T;
    • Norquist, Josephine M;
    • Lenderking, William R
    Publication type:
    journal article
    6

    The prevalence, severity, and correlates of psychological distress and impaired health-related quality of life following treatment for testicular cancer: a survivorship study.

    Published in:
    2016
    By:
    • Smith, Allan;
    • Butow, Phyllis;
    • Olver, Ian;
    • Luckett, Tim;
    • Grimison, Peter;
    • Toner, Guy;
    • Stockler, Martin;
    • Hovey, Elizabeth;
    • Stubbs, John;
    • Turner, Sandra;
    • Hruby, George;
    • Gurney, Howard;
    • Alam, Mahmood;
    • Cox, Keith;
    • King, Madeleine;
    • Smith, Allan Ben;
    • Toner, Guy C;
    • Stockler, Martin R;
    • King, Madeleine T
    Publication type:
    journal article
    7
    8
    9
    10

    Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer--The GCIG Symptom Benefit Study.

    Published in:
    Oncologist, 2017, v. 22, n. 9, p. 1117, doi. 10.1634/theoncologist.2017-0047
    By:
    • Roncolato, Felicia T.;
    • Joly, Florence;
    • O'Connell, Rachel;
    • Lanceley, Anne;
    • Hilpert, Felix;
    • Buizen, Luke;
    • Okamoto, Aikou;
    • Aotani, Eriko;
    • Pignata, Sandro;
    • Donnellan, Paul;
    • Oza, Amit;
    • Avall‐Lundqvist, Elisabeth;
    • Berek, Jonathan S.;
    • Heitz, Florian;
    • Feeney, Amanda;
    • Berton‐Rigaud, Dominique;
    • Stockler, Martin R.;
    • King, Madeleine;
    • Friedlander, Michael
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28

    International perspectives on suboptimal patient-reported outcome trial design and reporting in cancer clinical trials: A qualitative study.

    Published in:
    Cancer Medicine, 2021, v. 10, n. 16, p. 5475, doi. 10.1002/cam4.4111
    By:
    • Retzer, Ameeta;
    • Calvert, Melanie;
    • Ahmed, Khaled;
    • Keeley, Thomas;
    • Armes, Jo;
    • Brown, Julia M.;
    • Calman, Lynn;
    • Gavin, Anna;
    • Glaser, Adam W.;
    • Greenfield, Diana M.;
    • Lanceley, Anne;
    • Taylor, Rachel M.;
    • Velikova, Galina;
    • Brundage, Michael;
    • Efficace, Fabio;
    • Mercieca-Bebber, Rebecca;
    • King, Madeleine T.;
    • Kyte, Derek
    Publication type:
    Article
    29
    30

    Deriving a preference-based utility measure for cancer patients from the European Organisation for the Research and Treatment of Cancer's Quality of Life Questionnaire C30: a confirmatory versus exploratory approach.

    Published in:
    Patient Related Outcome Measures, 2014, v. 5, p. 119, doi. 10.2147/PROM.S68776
    By:
    • Costa, Daniel S. J.;
    • Aaronson, Neil K.;
    • Fayers, Peter M.;
    • Grimison, Peter S.;
    • Janda, Monika;
    • Pallant, Julie F.;
    • Rowen, Donna;
    • Velikova, Galina;
    • Viney, Rosalie;
    • Young, Tracey A.;
    • King, Madeleine T.
    Publication type:
    Article
    31
    32
    33

    Increased dopamine D.

    Published in:
    Synapse, 2009, v. 63, n. 6, p. 476, doi. 10.1002/syn.20624
    By:
    • King, Madeleine V.;
    • Seeman, Philip;
    • Marsden, Charles A.;
    • Fone, Kevin C.F.
    Publication type:
    Article
    34
    35
    36
    37
    38
    39

    Coping with metastatic melanoma: the last year of life.

    Published in:
    Psycho-Oncology, 2000, v. 9, n. 4, p. 283, doi. 10.1002/1099-1611(200007/08)9:4<283::AID-PON460>3.0.CO;2-N
    By:
    • Brown, Judith F.;
    • Brown, Rhonda F.;
    • Miller, Robyn M.;
    • Dunn, Stewart M.;
    • King, Madeleine T.;
    • Coates, Alan S.;
    • Butow, Phyllis N.
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50

    U.K. utility weights for the EORTC QLU-C10D.

    Published in:
    2019
    By:
    • Norman, Richard;
    • Mercieca‐Bebber, Rebecca;
    • Rowen, Donna;
    • Brazier, John E.;
    • Cella, David;
    • Pickard, A. Simon;
    • Street, Deborah J.;
    • Viney, Rosalie;
    • Revicki, Dennis;
    • King, Madeleine T.;
    • Mercieca-Bebber, Rebecca;
    • European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group and the MAUCa Consortium
    Publication type:
    journal article